SERCA2a gene therapy for heart failure: ready for primetime?
Periasamy
Muthu
M
Department of Physiology and Cell Biology, College of Medicine and Public Health, The Ohio State University, Columbus, Ohio 43210-1218, USA. Periasamy.1@osu.edu
Kalyanasundaram
Anuradha
A
D000818:Animals; D002118:Calcium / Q000378:metabolism; D002455:Cell Division; D002986:Clinical Trials as Topic; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006333:Heart Failure; D006801:Humans; D007249:Inflammation; D008954:Models, Biological; D051381:Rats; D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases / Q000235:genetics*
D053498:Sarcoplasmic Reticulum Calcium-Transporting ATPases; D002118:Calcium